KIT2014
PreclinicalSmall molecule
KIT2014 is one of 4 small molecule programs targeting Chronic Obstructive Pulmonary Disease (COPD). It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Chronic Obstructive Pulmonary Disease (COPD)
#DrugCompanyPhaseTrials
1Tezspire
AstraZenecaPhase 3
RC1416
NNanjing RegeneCore Biotech Co., Ltd.
Phase 2
Trimethoprim-Sulfamethoxazole
AstellasPreclinical
KIT2014
KKither Biotech Srl
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Chronic Obstructive Pulmonary Disease (COPD)1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for KIT2014. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- KKither Biotech Srl